More recently, mutations in EGFR have been identified in TNBC in up to ~11% (8/70) of Asian patients [28], although these mutations seem much rarer in European and Australian breast cancer cases, at 1.3% (3/229) and 0% (0/50), respectively [29, 30]. This evidence concerns the gene EGFR and breast carcinoma.